A review of the use of blood and blood products in HIV-infected patients

Southern African Journal of HIV Medicine

Volumn 13, Issue 2, 2012, Pages 87-103

  Van Den Berg, Karin ^a   Van Hasselt, James ^a   Bloch, Evan ^a   Crookes, Robert ^a   Kelley, James ^a   Berger, Jonathan ^a   Ingram, Charlotte ^a   Dippenaar, Anel ^a   Thejpal, Rajendra ^a   Littleton, Neil ^a   Elliz, Tersia ^a   Reubenson, Gary ^a   Cotton, Mark ^a   Hull, Jennifer C ^a   Moodley, Pamela ^a   Goga, Yasmin ^a   Eldridge, William ^a   Patel, Moosa ^a   Hefer, Eric ^a   Bird, Arthur ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIANEMIC AGENT; BLOOD CLOTTING FACTOR 8; COTRIMOXAZOLE; ERYTHROPOIETIN; FERROUS FUMARATE; FERROUS SULFATE; FIBRINOGEN; FIBRONECTIN; FRESH FROZEN PLASMA; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN; IRON; PREDNISONE; PROGESTERONE; THROMBOCYTE CONCENTRATE; TRANEXAMIC ACID; VON WILLEBRAND FACTOR; ZIDOVUDINE;

ANEMIA; AUTOIMMUNE THROMBOCYTOPENIA; BLOOD CELL COUNT; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; BONE MARROW CELL; CANCER PATIENT; CELL INFILTRATION; CLINICAL DECISION MAKING; CONSERVATIVE TREATMENT; DISSEMINATED INTRAVASCULAR CLOTTING; ERYTHROCYTE CONCENTRATE; HEMODILUTION; HEMOGLOBINOPATHY; HEMOPHILIA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOFIBRINOGENEMIA; INFECTION PREVENTION; IRON DEFICIENCY ANEMIA; IRON THERAPY; MALARIA; NEUTROPENIA; OBSTETRIC EMERGENCY; OBSTETRIC PATIENT; PANCYTOPENIA; PATIENT IDENTIFICATION; PLASMAPHERESIS; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PROGNOSIS; PURE RED CELL ANEMIA; REVIEW; SURGICAL PATIENT; THROMBOCYTE DISORDER; THROMBOCYTE POOR PLASMA; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT RESPONSE; VITAMIN K DEFICIENCY;

EID: 84865538541     PISSN: 16089693     EISSN: 20786751     Source Type: Journal    
DOI: 10.4102/sajhivmed.v13i2.146     Document Type: Review

References (77)

1. Beal RW. The rational use of blood. Australian And New Zealand Journal of Surgery 1976;46:309-313.
2. Evans RH, Scadden DT. Haematological aspects of HIV infection. Baillière's Best Practice & Research Clinical Haematology 2000;13:215-230.
3. Volberding PA, Baker KR, Levine AM. Human immunodeficiency virus hematology. Hematology/ The Education Program Of The American Society Of Hematology American Society Of Hematology Education Program 2003:294-313.
4. Claster S. Biology of anemia, differential diagnosis, and treatment options in human immunodeficiency virus infection. J Infect Dis 2002;185 Suppl 2:S105-S109.
5. Sloand E. Hematologic complications of HIV infection. AIDS Reviews 2005;7:187-196.
6. Sullivan P. Associations of anemia, treatments for anemia, and survival in patients with human immunodeficiency virus infection. J Infect Dis 2002;185 Suppl 2:S138-S142.
7. van Schalkwyk WA, Opie J, Novitzky N. The diagnostic utility of bone marrow biopsies performed for the investigation of fever and/or cytopaenias in HIV-infected adults at Groote Schuur Hospital, Western Cape, South Africa. International Journal of Laboratory Hematology 2011;33:258-266.
8. Mocroft A, Kirk O, Barton SE, et al. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group. AIDS (London, England) 1999;13:943-950.
9. Moore RD, Keruly JC, Chaisson RE. Anemia and survival in HIV infection. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1998;19:29-33.
10. Dainiak N, Worthington M, Riordan MA, Kreczko S, Goldman L. 3'-Azido-3'-deoxythymidine (AZT) inhibits proliferation in vitro of human haematopoietic progenitor cells. Br J Haematol 1988;69:299-304.
11. Kiragga AN, Castelnuovo B, Nakanjako D, Manabe YC. Baseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings. Journal of The International AIDS Society 2010;13:42.
12. Lawrie D, Coetzee LM, Becker P, Mahlangu J, Stevens W, Glencross DK. Local reference ranges for full blood count and CD4 lymphocyte count testing. S Afr Med J 2009;99:243-248.
13. Lotspeich-Steininger C, Stiene-Martin E, Koepke J, eds. Clinical Hematology: Principles, Procedures, Correlations. Philadelphia: Lippincott-Raven, 1998.
14. Afacan YE, Hasan MS, Omene JA. Iron deficiency anemia in HIV infection: immunologic and virologic response. Journal of The National Medical Association 2002;94:73-77.
15. Carmel R. Treatment of severe pernicious anemia: no association with sudden death. Am J Clin Nutr 1988;48.
16. McMullin MF, Cuthbert RJ. Transfusion in the management of patients with megaloblastic anaemia. Int J Clin Pract 1999;53:104-106.
17. Volberding P. Consensus statement: anemia in HIV infection-current trends, treatment options, and practice strategies. Anemia in HIV Working Group. Clin Ther 2000;22:1004-1020.
18. Volberding PA, Levine AM, Dieterich D, Mildvan D, Mitsuyasu R, Saag M. Anemia in HIV infection: clinical impact and evidence-based management strategies. Clin Infect Dis 2004;38:1454-1463.
19. Telen MJ, Roberts KB, Bartlett JA. HIV-associated autoimmune hemolytic anemia: report of a case and review of the literature. J Acquir Immune Defic Syndr 1990;3:933-937.
20. Saif MW. HIV-associated autoimmune hemolytic anemia: an update. AIDS Patient Care And Stds 2001;15:217-224.
21. Salama A, Berghöfer H, Mueller-Eckhardt C. Red blood cell transfusion in warm-type autoimmune haemolytic anaemia. Lancet 1992;340:1515-7.
22. Sullivan PS, Hanson DL, Chu SY, Jones JL, Ciesielski CA. Surveillance for thrombocytopaenia in persons infected with HIV: results from the multistate Adult and Adolescent Spectrum of Disease Project. Journal Of Acquired Immune Deficiency Syndromes And Human Retrovirology 1997;14:374-379.
23. Coyle TE. Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Med Clin North Am 1997;81:449-470.
24. Passos AM, Treitinger A, Spada C. An overview of the mechanisms of HIV-related thrombocytopaenia. Acta Haematologica 2010;124:13-18.
25. Scaradavou A. HIV-related thrombocytopaenia. Blood Reviews 2002;16:73-76.
26. Miguez-Burbano MJ, Jackson J Jr, Hadrigan S. Thrombocytopaenia in HIV disease: clinical relevance, physiopathology and management. Current Medicinal Chemistry Cardiovascular and Hematological Agents 2005;3:365-376.
27. Burbano X, Miguez MJ, Lecusay R, et al. Thrombocytopaenia in HIV-infected drug users in the HAART era. Platelets 2001;12:456-461.
28. Ehmann WC, Rabkin CS, Eyster ME, Goedert JJ. Thrombocytopaenia in HIV-infected and uninfected hemophiliacs. Multicenter Hemophilia Cohort study. Am J Hematol 1997;54:296-300.
29. Trattner A, Hodak E, David M, Sandbank M. The appearance of Kaposi sarcoma during corticosteroid therapy. Cancer 1993;72:1779-1783.
30. Novitzky N, Thomson J, Abrahams L, du Toit C, McDonald A. Thrombotic thrombocytopenic purpura in patients with retroviral infection is highly responsive to plasma infusion therapy. Br J Haematol 2005;128:373-379.
31. Moore RD, Keruly JC, Chaisson RE. Neutropaenia and bacterial infection in acquired immunodeficiency syndrome. Arch Intern Med 1995;155:1965-1970.
32. Murphy MF, Metcalfe P, Waters AH, et al. Incidence and mechanism of neutropaenia and thrombocytopaenia in patients with human immunodeficiency virus infection. Br J Haematol 1987;66:337-340.
33. Medical Directors of the South African Blood Transfusion Services. Clinical Guidelines for the use of Blood Products in South Africa. Fourth ed, 2008.
34. World Health Organization. Pocket book of hospital care for children. Guidelines for the Management of Common Illnesses with Limited Resources. 2005.
35. Greenberg AE, Nguyen-Dinh P, Mann JM, et al. The association between malaria, blood transfusions, and HIV seropositivity in a pediatric population in Kinshasa, Zaire. JAMA 1988;259:545-549.
36. English M, Ahmed M, Ngando C, Berkley J, Ross A. Blood transfusion for severe anaemia in children in a Kenyan hospital. Lancet 2002;359:494-495.
37. Obonyo CO, Steyerberg EW, Oloo AJ, Habbema JD. Blood transfusions for severe malaria-related anemia in Africa: a decision analysis. Am J Trop Med Hyg 1998;59:808-812.
38. Thejpal R. Unravelling the Cytopaenias in HIV Infected Children. Johannesburg: SAPA/IPA, 2010.
39. Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med 2008;36:2667-2674.
40. Cheema B, Molyneux EM, Emmanuel JC, et al. Development and evaluation of a new paediatric blood transfusion protocol for Africa. Transfusion Medicine (Oxford, England) 2010;20:140-151.
41. World Health Organization. The Clinical Use of Blood in Medicine, Obstetrics, Paediatrics, Surgery & Anaesthesia, Trauma & Burns. Geneva: World Health Orbanization, 2001.
42. Hébert PC, Wells G, Tweeddale M, et al. Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group. Am J Respir Crit Care Med 1997;155:1618-1623.
43. Lacroix J, Hébert PC, Hutchison JS, et al. Transfusion strategies for patients in pediatric intensive care units. New Engl J Med 2007;356:1609-1619.
44. Kirpalani H, Whyte RK, Andersen C, et al. The premature infants in need of transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr 2006;149:301-307.
45. Gibson BES, Todd A, Roberts I, et al. Transfusion guidelines for neonates and older children. Br J Haematol 2004;124:433-453.
46. Hu K, Harrison LB. Impact of anemia in patients with head and neck cancer treated with radiation therapy. Curr Treat Options Oncol 2005;6:31-45.
47. Fenton PM. Managing situations of acute blood loss with limited resources. Transfusion Alternatives in Transfusion Medicine 2008;10:82-89.
48. Safe Transfusion Practice in Sub-Saharan Africa - A Manual for Field Workers. 2010. http://www. safetransfusionmanual.org/2010/03/ indicationssurgical- patient.html.
49. Spence RK, Carson JA, Poses R, et al. Elective surgery without transfusion: influence of preoperative hemoglobin level and blood loss on mortality. Am J Surg 1990;159:320-324.
50. Carson JL, Noveck H, Berlin JA, Gould SA. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion 2002;42:812-818.
51. Nelson L, Fried M, Stewart K. The risks of surgery in HIV-infected patients. J Perioper Pract 2007;17:470.
52. Avidan MS, Jones N, Pozniak AL. The implications of HIV for the anaesthetist and the intensivist. Anaesthesia 2000;55:344-354.
53. Prout J, Agarwal B. Anaesthesia and critical care for patients with HIV infection. Continuing Education in Anaesthesia, Critical Care & Pain 2005;5:153-156.
54. Committee for Confidential Enquiry into Maternal Mortality in South Africa. Saving Mothers Report, 2002-2004. Confidential Enquiry into Maternal Mortality in South Africa. Pretoria: Department of Health, 2006.
55. Blood Transfusion Committee Statistics. Johannesburg: Chris Hani Baragwanath Hospital Blood Transfusion Committee, 2010.
56. Hytten F. Blood volume changes in normal pregnancy. Clinics In Haematology 1985;14:601-612.
57. Rose NC, Mennuti MT. Periconceptional folate supplementation and neural tube defects. Clin Obstet Gynecol 1994;37:605-620.
58. van den Broek NR, Letsky EA. Etiology of anemia in pregnancy in south Malawi. Am J Clin Nutr 2000;72:247S-256S.
59. Prevention of Mother to Child Transmission. Pretoria: South African National Aids Council, 2010.
60. Bendich A. Calcium supplementation and iron status of females. Nutrition 2001;17:46-51.
61. Hallberg L, Brune M, Rossander L. Iron absorption in man: ascorbic acid and dose-dependent inhibition by phytate. Am J Clin Nutr 1989;49:140-144.
62. Snower D, Weil S. Changing aetiology of macrocytosis: zidovudine as a frequent causative factor. Am J Clin Pathol 1993;99:57-60.
63. Blood Transfusion in Obstetrics. London: Royal College of Obstetricians and Gynaecologists, 2007.
64. Balakrishnan A, Valsalan R, Sheshadri S, Pandit VR, Medep V, Agrawal RK. Zidovudine-induced reversible pure red cell aplasia. Indian Journal Of Pharmacology 2010;42:189-191.
65. Practice guidelines for obstetric anesthesia: an updated report by the American Society of Anesthesiologists Task Force on Obstetric Anesthesia. Anesthesiology 2007;106:843-863.
66. Cohen C, Karstaedt A, Frean J, et al. Increased prevalence of severe malaria in HIV-infected adults in South Africa. Clin Infect Dis 2005;41:1631-1637.
67. Malaria and HIV/AIDS Interactions and Implications: Conclusions of a Technical Consultation convened by WHO. Geneva: World Health Organization, 2004.
68. Meremikwu M, Smith HJ. Blood transfusion for treating malarial anaemia. Cochrane Database Of Systematic Reviews (Online) 2000:CD001475.
69. Tolentino K, Friedman JF. An update on anemia in less developed countries. Am J Trop Med Hyg 2007;77:44-51.
70. Davenport GC, Ouma C, Hittner JB, et al. Hematological predictors of increased severe anemia in Kenyan children coinfected with Plasmodium falciparum and HIV-1. Am J Hematol 2010;85:227-233.
71. Gwer S, Newton CRJC, Berkley JA. Over-diagnosis and co-morbidity of severe malaria in African children: a guide for clinicians. Am J Trop Med Hyg 2007;77:6-13.
72. Guidelines for the Treatment of Malaria 2009, Pretoria: Department of Health, 2009.
73. Collier AC, Kalish LA, Busch MP, et al. Leukocytereduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA 2001;285:1592-1601.
74. Drew WL, Chou S, Mohr BA, et al. Absence of activation of CMV by blood transfusion to HIVinfected, CMV-seropositive patients. Transfusion 2003;43:1351-1357.
75. Buskin SE, Sullivan PS. Anemia and its treatment and outcomes in persons infected with human immunodeficiency virus. Transfusion 2004;44:826-832.
76. Hébert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. New Engl J Med 1999;340:409-417.
77. Moore RD. Anemia and human immunodeficiency virus disease in the era of highly active antiretroviral therapy. Semin Hematol 2000;37:18-23.